Rosiglitazone attenuates suppression of RXRalpha-dependent gene expression in inflamed liver.
about
Clinical application of transcriptional activators of bile salt transporters.Nuclear receptors: mediators and modifiers of inflammation-induced cholestasis.Extrahepatic cancer suppresses nuclear receptor-regulated drug metabolism.Role of high-fat diet in regulation of gene expression of drug metabolizing enzymes and transporters.Nuclear receptors as drug targets in cholestatic liver diseases.Inflammatory mediators increase SUMOylation of retinoid X receptor α in a c-Jun N-terminal kinase-dependent manner in human hepatocellular carcinoma cells.Regulation of gene expression of hepatic drug metabolizing enzymes and transporters by the Toll-like receptor 2 ligand, lipoteichoic acid.Effects of three different fibrates on intrahepatic cholestasis experimentally induced in rats.Nuclear receptors as therapeutic targets in cholestatic liver diseases.Nuclear receptors in the cross-talk of drug metabolism and inflammation.Redundant roles for cJun-N-terminal kinase 1 and 2 in interleukin-1beta-mediated reduction and modification of murine hepatic nuclear retinoid X receptor alpha.Gene-specific alterations of hepatic gene expression by ligand activation or hepatocyte-selective inhibition of retinoid X receptor-α signalling during inflammation.Role of c-Jun-N-terminal kinase in pregnane X receptor-mediated induction of human cytochrome P4503A4 in vitro.Protective effects of kaerophyllin against liver fibrogenesis in rats.Role of Toll-like receptor 4 in drug-drug interaction between paclitaxel and irinotecan in vitro.PPAR-gamma activation is associated with reduced liver ischemia-reperfusion injury and altered tissue-resident macrophages polarization in a mouse model.
P2860
Q33709930-15F23E9F-52E4-4B52-AEBE-102BE510C6EEQ33859400-6F41A033-5241-4342-9129-4A82B91F9A21Q34987988-0BBA60BB-7296-491C-B159-802D940349DCQ35166776-4755F56B-7996-47EE-B593-942E06EED06CQ36786270-24394ACA-8F52-4BC8-8A6A-B62CF2DC04C6Q37027067-07AE5ACB-8B0A-4894-BFB4-F7E236C5485CQ37082070-58B639A1-C5E0-49C4-A6E4-CD78055E8CDFQ37122494-CD4474E5-9618-400E-A419-6083CA6ECBB0Q37230857-EEEB0DAC-A054-4896-AA1D-E5BF517484FBQ38074993-05AD50BD-BD2F-4C94-AFCC-4CA4827BDDA3Q41812163-CF164C24-4967-4B33-9EB7-6B58F6AA8B73Q42106445-12C7101A-2335-44B4-9A0B-343D40039806Q50027324-9984B419-5568-4CD5-82A9-F80A16A98369Q53204213-FE0E4B47-B112-40DD-B111-1036203AD22DQ53749471-1A7A7A6C-AE7E-4FC2-AAC2-7894A4B00C51Q55004343-44B3A720-7451-45DA-BA75-A1FB2352C457
P2860
Rosiglitazone attenuates suppression of RXRalpha-dependent gene expression in inflamed liver.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Rosiglitazone attenuates suppr ...... expression in inflamed liver.
@ast
Rosiglitazone attenuates suppr ...... expression in inflamed liver.
@en
type
label
Rosiglitazone attenuates suppr ...... expression in inflamed liver.
@ast
Rosiglitazone attenuates suppr ...... expression in inflamed liver.
@en
prefLabel
Rosiglitazone attenuates suppr ...... expression in inflamed liver.
@ast
Rosiglitazone attenuates suppr ...... expression in inflamed liver.
@en
P2093
P2860
P1476
Rosiglitazone attenuates suppr ...... expression in inflamed liver.
@en
P2093
Folkert Kuipers
Jaap Mulder
Richard J von Furstenberg
Romi Ghose
Saul J Karpen
Sundararajah Thevananther
P2860
P304
P356
10.1016/J.JHEP.2006.09.008
P577
2006-10-23T00:00:00Z